Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 46 of 97, showing 5 Applications out of 482 total, starting on record 226, ending on 230

# Protocol No Study Title Investigator(s) & Site(s)

226.

ECCT/20/08/04   LOW DOSE RADIATION THERAPY
    A pilot phase Ib/II study of whole-lung low dose radiation therapy (LDRT) in the treatment of severe Covid 19 pneumonia patients on (or requiring) mechanical ventilatory support   
Principal Investigator(s)
1. PROF. MANSOOR SALEH
Site(s) in Kenya
Aga Khan University Hospital, Nairobi
 
View

227.

ECCT/20/09/01   PrEP in Pharmacy - PILOT STUDY
    Pharmacy delivery to expand the reach of PrEP in Kenya: Pilot study       
Principal Investigator(s)
1. Kenneth Kairu Ngure
Site(s) in Kenya
KEMRI-CCR PHRD (THIKA) PROJECT
 
View

228.

ECCT/20/10/02   MALCOV
    Malaria as a risk factor for COVID-19 in western Kenya and Burkina Faso (MALCOV)   
Principal Investigator(s)
1. Simon Kariuki
2. Helen Barsosio
Site(s) in Kenya
1. Jaramogi Oginga Odinga Teaching and Referral Hospital (JOORTH), (Kisumu county)
2. Kisumu County Referral Hospital. (Kisumu county)
3. Alupe sub-County Hospital, (Busia county)
4. Bondo sub-County Hospital, (Siaya county)
5. Macalder (Nyatike) sub-County Hospital (Migori county)
6. Migori County Teaching and Referral Hospital; (Migori county)
 
View

229.

ECCT/20/08/02   ALIVE study
    Evaluation of the effectiveness of IVERMECTIN co-formulation vs ALBENDAZOLE for treatment of for the Treatment of Soil-Transmitted Helminth Infections (Trichuris trichiura, hookworm, Strongyloides stercoralis) in school aged children and Young Adult Subjects (ALIVE Study)   
Principal Investigator(s)
1. Charles Mwandawiro
Site(s) in Kenya
Kwale
 
View

230.

ECCT/20/07/02   RV 460 HIV Vaccine Trial
    A Randomized, Double-Blind Phase 1 Trial to Evaluate the Safety and Immunogenicity of   Priming with Env-C Plasmid DNA Vaccine Alone, with Different Adjuvants, or with an   Adjuvanted HIV Env gp145 C.6980 Protein Vaccine and Boosting with the Adjuvanted   HIV Env gp145 C.6980 Protein Vaccine with or without the Env-C Plasmid DNA Vaccine   in Healthy HIV Uninfected Adults in Kenya   
Principal Investigator(s)
1. Josphat Kosgei
Site(s) in Kenya
KEMRI/US MRDA-A/K, KERICHO
 
View